Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Patent
1995-11-09
1999-04-06
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
424441, 426648, 426656, 514564, 514565, A23L 1305, A61K 900, A61K 31195
Patent
active
058914595
ABSTRACT:
Vascular function and structure is maintained or improved by long term administration of physiologically acceptable compounds, namely L-arginine, L-lysine, physiologically acceptable salts thereof, and polypeptide precursors thereof, which enhance the level of endogenous nitric oxide or other intermediates in the NO induced relaxation pathway in the host. In or in combination, other compounds, such as B.sub.6, folate, B.sub.12, or an antioxidant, which provide for short term enhancement of nitric oxide, either directly or by physiological processes may be employed.
REFERENCES:
patent: 3970750 (1976-07-01), Brockmeyer et al.
patent: 4340592 (1982-07-01), Adibi
patent: 4920098 (1990-04-01), Cottes et al.
patent: 5032608 (1991-07-01), Dudrick
patent: 5034377 (1991-07-01), Adibi et al.
patent: 5106836 (1992-04-01), Clemen et al.
patent: 5157022 (1992-10-01), Barbul
patent: 5171217 (1992-12-01), March et al.
patent: 5217997 (1993-06-01), Levere et al.
patent: 5278189 (1994-01-01), Rath et al.
patent: 5364644 (1994-11-01), Walaszek et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5464644 (1995-11-01), Wullschleger et al.
patent: 5543430 (1996-08-01), Kaesemeyer
patent: 5576287 (1996-11-01), Zaloga et al.
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5626883 (1997-05-01), Paul
patent: 5631031 (1997-05-01), Mead
patent: 5650418 (1997-07-01), Rath et al.
patent: 5767160 (1998-06-01), Kaesemeyer
patent: 5780039 (1998-07-01), Greenberg et al.
Ignarro et al. Basic Polyamino Acids Rich in Arginine . . . Circ. Res. Feb. 1989, vol. 64, No. 2, pp. 315-329.
McNamara et al. L. Arginine Inhibits Balloon Catheter . . . Biochem. Biophys. Res. Comm. 28 May 1993, vol. 193, No. 1, pp. 291-296.
Rock et al. L-arginyl-L-lysine and L-arginyl-L-arginine . . . Med.Sci.Res. 1990, vol. 18, pp. 165-166.
Andrews et al., "Low-density Lipoproteins inhibit endothelium-dependent Relaxation in Rabbit Aorta", Nature (1987), 327:237-239.
Bath et al., "Nitric Oxide and Prostacyclin: Divergence of Inhibitory Effects on Monocyte Chemotaxis and Adhesion to Endothelium in Vitro", Arterioscierosis and Thrombosis (1991), 11:254-260.
Cooke, "Endothelial Dysfunction in Disease States", Current Opinion in Cardiology (1990), 5:637-644.
Drexler et al., "Correction of Endothelial Dysfunction in Coronary Micocirculation of Hypercholesterolaemic Patients", The Lancet (1991), 338:1546-1550.
Garg and Hassid, "Nitric Oxide-generating Vasodilators and 8-Bromo-Cyclic Guanosine Monophosphate Inhibit Mitrogenesis and Proliferation of Cultured Rat Vascular Smooth Muscle Cells", J. Clin. Invest. (1989), 83:1774-1777.
Girerd et al., "L-Arginine Augments Endothelium-Dependent Vasodilation in Cholesterol-Fed Rabbits", Circulation Research (1990), 67:1301-1308.
Heistad et al., "Augmented Responses to Vasoconstrictor Stimuli in Hypercholesterolemic and Atherosclerotic Monkeys", Circulation Research (1984), 54:711-718.
Kubes et al., "Nitric Oxide: An Endogenous Modulator of Leukocyte Adhesion", PNAS USA (1991), 88:4651-4655.
Kugiyama et al., "Impairment of Endothelium-Dependent Arterial Relaxation by Lysolecithin in Modified Low-density Lipoproteins", Nature (1990), 344:160-162.
Kuo et al., "Pathophysiological Consequences of Atherosclerosis Extend Into the Coronary Microcirculation: Restoration of Endothelium-dependent Responses by L-Arginine", Circulation Research (19920, 70:465-476.
Lefer et al., "Role of Endothelium-derived Relaxing Factor as a Cardioprotective Agent in Myocardial Ischemia", Basil, Karger (1990), 190-197.
Minor et al., "Diet-induced Atherosclerosis Increases the Release of Nitrogen Oxides from Rabbit Aorta", J. Clin. Invest. (1990), 86:2109-2116.
Mitchell et al., "Native LDL Inhibits the Release of Endothelial Derived Relaxing Factors by Reducing the Activity of Endothelial Nitric Oxide Synthase", (Abstract), J. Vasc. Res. (1992), 29:169.
Pohl and Busse, "EDRF Increases Cyclic GMP in Platelets During Passage Through the Coronary Vascular Bed", Circulation Research (1989), 65:1798-1803.
Radomski et al., "Comparative Pharmacology of Endothelium-derived Relaxing Factor, Nitric Oxide and Prostacyclin in Platelets", Br. J. Pharmacol. (1987), 92:181-187.
Ross, "The Pathogenesis of Atherosclerosis--an Update", The New England Journal of Medicine (1986), 314:488-500.
Rossitch, Jr. et al., "L-Arginine Normalizes Endothelial Function in Cerebral Vessels from Hypercholesterolemic Rabbits", J. Clin. Invest., 87:1295-1299 (1991).
Stamler et al., "N-Acetylcysteine Potentiates Platelet Inhibition by Endothelium-derived Relaxing Factor", Circulation Research (1989), 65:789-795.
Tanner et al., "Oxidized Low Density Lipoproteins Inhibit Relaxations of Porcine Coronary Artieries: Role of Scavenger Receptor and Endotheiium-derived Nitric Oxide", Circulation, 83:2109-2116 (1991).
Tomita et al., "Rapid and Reversible Inhibition by Low Density Lipoprotein of the Endothelium-dependent Relaxation to Hemostatic Substances in Porcine Coronary Arteries", Circulation Research (1990), 66:18-27.
Weidinger et al., "Persistent Dysfunction of Regenerated Endothelium After Balloon Angioplasty of Rabbit lliac Artery", Circulation (1990), 81:1667-1679.
Yamamoto et al., "Videomicroscopic Demonstration of Defective Cholinergic Arteriolar Vasodilation in Atherosclerotic Rabbit", J. Clin. Invest. (1988), 81:1752-1758.
Lankin, "Atherosclerosis as a Free Radical Pathology", Inst. Congr. Ser. Excerpta Med. (1992), 998:385-8.
Zembowicz, "The Biological Role of L-Arginine/Nitric Oxide Pathway", Folia Med. Cracov. (1992), 33:103-116.
Cooke John P.
Dzau Victor J.
Gibbons Gary H.
Rowland Bertram I.
Russel Jeffrey E.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Enhancement of vascular function by modulation of endogenous nit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of vascular function by modulation of endogenous nit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of vascular function by modulation of endogenous nit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1368771